Skip to main content
. 2020 Dec 23;13(1):12. doi: 10.3390/pharmaceutics13010012

Table 3.

Study demographics of the clinical Phase 1 study.

Parameter Age Body Mass Index (BMI)
Mean 44 ± 6 26 ± 3
Median 46 26.5
Range 31–50 22.4–29.4